X4 Pharmaceuticals, Inc. (XFOR)
3.775
+0.14
(+3.71%)
USD |
NASDAQ |
May 20, 16:00
3.94
+0.16
(+4.37%)
After-Hours: 06:16
X4 Pharmaceuticals EPS Diluted (Quarterly) : -0.1603 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Immuneering Corp. | -0.2082 |
| vTv Therapeutics, Inc. | 1.649 |
| Editas Medicine, Inc. | -0.2552 |
| Design Therapeutics, Inc. | -0.2871 |
| Tango Therapeutics, Inc. | -0.317 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.24M |
| Revenue (Quarterly) | 2.708M |
| Total Expenses (Quarterly) | 22.95M |
| Enterprise Value | 186.86M |
| Gross Profit Margin (Quarterly) | 76.59% |
| Profit Margin (Quarterly) | -747.5% |
| Earnings Yield | -120.2% |
| Normalized Earnings Yield | -126.54 |